Bcl-2 Monoclonal Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) .
Synonyms
Apoptosis regulator Bcl 2; Apoptosis regulator Bcl2; AW986256; B cell CLL/lymphoma 2; B cell leukemia/lymphoma 2; B cell lymphoma 2; Bcl 2; Bcl-2; Bcl2; BCL2 protein; C430015F12Rik; D630044D05Rik; D830018M01Rik; Leukemia/lymphoma, B-cell, 2; Oncogene B-cell leukemia 2; BCL2_HUMAN.
Gene ID
596
Swiss Prot
P10415
Host
Mouse
Cross Reactivity
Human, Mouse, Rat
Immunogen
51-150/239
Target
Bcl-2
Clonality
Monoclonal
Isotype
IgG
Clone
8B5
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human Bcl2
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
596
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1136018-01 0.02 mg (E-Coli)
Recombinant Chloroherpeton thalassium 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details 
MBS1136018-02 0.1 mg (E-Coli)
Recombinant Chloroherpeton thalassium 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details MBS1136018-03 0.02 mg (Yeast)
Recombinant Chloroherpeton thalassium 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details MBS1136018-04 0.1 mg (Yeast)
Recombinant Chloroherpeton thalassium 7-cyano-7-deazaguanine synthase (queC)
Sign In for Pricing
View Details